je.st
news
Isis Pharmaceuticals: - The Best Pipeline in Biotech,' Potential Takeover Target
2014-05-23 21:19:24| Biotech - Topix.net
Shares of Isis Pharmaceuticals have gained 9% to $27.20 at 1:26 p.m. today, easily besting similar biotech companies like Alnylam Pharmaceuticals , which has risen 3.8% to $57.67, and Sarepta Therapeutics , which has advanced 4.1% to $33.88.
Tags: potential
target
biotech
pipeline
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||